Cite
HARVARD Citation
Anastasiou, D. et al. (n.d.). 1342. Comparison of Lysin CF-301 (Exebacase) Activity Against S. aureus Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102) to Contemporary Surveillance Isolates. Open forum infectious diseases. p. S410. [Online].